💉 Next-Gen Long-Acting Shots Are Loading
Published by OOPSONLINE.IN · Source: News-Medical.net · 1 min read · · Updated
🔥 OOPS SAYS
"PharmaShell" sounds like the starter armor you equip in a sci-fi RPG, but we are absolutely ready for our medicine to get a high-tech tactical upgrade.
What actually happened
Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. ("Archimedes II"), today announced a Joint Development Agreement ("JDA") with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell® drug delivery platform and its portfolio of proprietary and partnered programs.
Key points
- , a leading U.
- -based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co.
- ("Archimedes II"), today announced a Joint Development Agreement ("JDA") with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell® drug delivery platform and its portfolio of proprietary and partnered programs.
Summary based on data provided by News-Medical.net. Full article available at the original publisher.
- #ai
- #forge
- #nano